Therapeutic role of mitoxantrone in multiple sclerosis
- 10 August 2005
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 109 (1-2) , 198-209
- https://doi.org/10.1016/j.pharmthera.2005.07.002
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Noninvasive Assessment of Mitoxantrone Cardiotoxicity in Relapsing Remitting Multiple SclerosisThe Journal of Clinical Pharmacology, 1995
- Suppression of demyelination by mitoxantroneInternational Journal of Immunopharmacology, 1991
- MitoxantroneDrugs, 1991
- Pharmacokinetics and Metabolism of MitoxantroneClinical Pharmacokinetics, 1990
- Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantroneClinical Immunology and Immunopathology, 1987
- Effects of chronic administration of doxorubicin on myocardial beta-adrenergec receptorsLife Sciences, 1986
- Suppression of experimental allergic encephalomyelitis by mitoxantroneClinical Immunology and Immunopathology, 1985
- Rating neurologic impairment in multiple sclerosisNeurology, 1983